CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad ...

Bio-Rad Laboratories said today it acquired GnuBIO, in a deal that expands the acquiring company’s droplet-based DNA sequencing technology offerings within its portfolio of clinical diagnostics ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...

Bio-Rad, others alleged Stilla Technologies infringed 'droplet' patents Parties settled three days after trial began (Reuters) - Bio-Rad Laboratories has settled its patent infringement claims against ...